IndigoGiving people with diabetes the extra sense for health
We’re developing the world’s first continuous multi-metabolite monitoring (CMM) system for people living with diabetes.
Diabetes accounts for 12% of the global health expenditure and is the 5th leading cause of early death.
Our technology uses ground-breaking nanophotonics technology to analyze levels of metabolites via an on-chip miniature spectrometer.
Explore the Indigo Story
Less Hassle - More Quality of Life
One out of eleven people in the world lives with diabetes and has to keep an eye on blood sugar levels every day.
Today, this is often both painful and stigmatizing. Indigo is developing a sensor that is designed to make blood sugar checking invisible and painless in the future. The small sensor will be inserted just under the skin and aims to measure not only glucose, but also ketones for up to 2 years in the body.
The Indigo receiver will be designed so that users will be able to display trends, values and warnings in real-time on their smartphone or any other connected device. Via the Indigo app, users will be able to share their data with others, and to analyze them further.
The invisible Indigo sensor will make finger pricking and visible patches on the skin for glucose monitoring a thing of the past. Continuous ketone monitoring will bring additional peace of mind to people with diabetes.
Latest News And Events
Indigo Diabetes Receives €3 million Hephaestus Research Grant to Support Development of CMM Technology
BELGIUM - Ghent, September 7, 2021 – Indigo Diabetes N.V. (‘Indigo’ or the ‘Company’), a pioneering developer of medical solutions using nanophotonics, is pleased to announce that it has received a €3 million grant from VLAIO, the Flanders organisation for Innovation...
We are pleased to announce the appointment of Paul Moraviec as Chairman of our Board of Directors Paul Moraviec - Brings decades of leadership experience in the Global MedTech sector - As CEO of ConvaTec Group Plc, led the $5 billion IPO on the London Stock Exchange -...
Our CEO and co-founder Danaë Delbeke was one of the 35 CEOs from start-ups and unicorn companies (companies worth more than $1bn), who met on 30th March 2021 in a digital roundtable event organised by the European Commission. The aim of the event which was hosted by...
“We are proud to pioneer groundbreaking technology that will have a positive impact on the life of millions of people living with diabetes.”
– Danaë Delbeke